How cells relieve DNA replication stress

December 23, 2019

DNA stores all of the information necessary for life phenomena, and a cell transmits its own genetic information to two daughter cells through DNA replication and cell division. Replication stress can be caused by extracellular and intracellular sources during DNA replication, which leads to slowed or stalled replication. If cells do not properly cope with such risks, chromosome break and rearrangement will occur, resulting in genomic instability. That helps explain why replication stress is one of the major contributors to cancer development.

Although many DNA repair proteins function to protect and restart stalled replication process under stress condition, it is still unclear how replisome proteins, which are real players in DNA replication, contribute and communicate with those proteins to ensure faithful DNA replication. Led by director Kyungjae Myung and Dr. Kyoo-young Lee, a research group at the Center for Genomic Integrity within the Institute for Basic Science (IBS) at the Ulsan National Institute of Science and Technology (UNIST), South Korea revealed that ATAD5 actively deals with replication stress, in addition to its known function to prevent such stressful situations. Though ATAD5 has been known as a tumor suppressor by maintaining genomic stability and suppressing tumorigenesis, it has been unclear whether the replication regulatory protein is also involved in the replication stress response. "We have identified the fundamental mechanism of replication stress control, which is a major cause of cancer. Hopefully our work will contribute to the development of cancer therapy," explains director Myung.

Director Kyungjae Myung group recently found that ATAD5 regulates the functions of PCNA, one of main replication proteins by removing the ring-shaped PCNA from DNA to ensure a complete end of its cycling. ATAD5-depleted cells show characteristic features of replication stress such as a slow replication rate. Although the PCNA-regulating activity of ATAD5 may be the cause of this cellular response to its depletion, the researchers hypothesized that ATAD5 may have an additional role in counteracting replication stress. ATAD5 proteins play an important role in the DNA replication process itself, so experimentally reducing the amount of ATAD5 in cells results in many abnormalities associated with normal DNA replication. Because replication stress, which is focused in this study, also occurs during the DNA replication, it is critical to separate the effects of ATAD5 deficiency on the replication stress and the general DNA replication process. To overcome this, the researchers devised an experimental method to induce ATAD5 deficiency at the beginning of replication stress.

Under these experimental conditions, they found that, when ATAD5 level is reduced, cells cannot resume DNA replication stalled by replication stress, but increases genome instability such as intracellular chromosome breakage and micronucleated reticulocytes in mouse blood. This means that ATAD5 contributes to maintaining genomic stability by restoring DNA replication under replication stress. Thereafter, they conducted experiments to elucidate the molecular mechanism for ATAD5 restarting DNA replication. RAD51 plays critical roles in structural changes and stability of stalled replication sites under replication stress. The researchers found that ATAD5 promotes RAD51 recruitment to stalled replication sites by direct protein-protein interaction.

In addition, they reported that PCNA unloading by ATAD5 is a prerequisite for efficient RAD51 recruitment. These suggest that a series of processes starting with RAD51 recruitment and leading to structural changes, breakage, and eventual replication restart are regulated by ATAD5. These findings highlight that the role of ATAD5 in maintaining genome stability extends beyond its roles in PCNA unloading during normal DNA replication. Dr. Su Hyung Park, the first author of this study notes, "Mutations in the ATAD5 gene are frequently found in many cancer cells. This study contributes to understating the cause of tumor formation by ATAD5 mutations."

Replication stress can be caused by extracellular sources such as oncogenes and chemicals. However, recent studies have shown that intracellular sources such as DNA-specific structures or the abnormal function of specific proteins can also provoke replication stress. In addition to enhancing our understanding of initial cellular responses to replication stress, this study provides us a novel conceptual advance that a protein can play dual roles in managing replication stress: the preemptive prevention and the resolution of replication stress. Dr. Kyoo-young Lee, the corresponding author of this study says, "In the future, we will examine how the internal factors cause replication stress and how the cells selectively recognize and cope with different stressor."
-end-


Institute for Basic Science

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.